Discover 2,010 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,010
Neoadjuvant Darovasertib in Primary Uveal Melanoma
for
Uveal Melanoma
Location: New York NY, Baltimore MD, Toronto, Jacksonville FL,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07015190
Phase3, Recruiting
Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs
for
Platelet Function and Reactivity Tests
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 18 - 70+
Code: NCT06933056
Early_phase1, Recruiting
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Location: Boston MA, Detroit MI, Atlanta GA
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07393282
Phase3, Recruiting
FOCUS ON US: Adapting the FOCUS Program for Sexual and Gender Minority (SGM) Cancer Patients and Caregivers
for
Cancer Support, Oncology Patients, Caregivers
Location: Rochester NY, Detroit MI
Sponsor: Charles Kamen
Sex: All
Age: 18 - 70+
Code: NCT06800053
Recruiting
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control
for
Myopia
Location: Boston MA, Philadelphia PA, Norfolk VA, Durham NC,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 5 - 11
Code: NCT07095894
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Location: Scarborough ME, The Bronx NY, Albany NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT07022678
Phase3, Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease